Analyse des dispositifs orthopédiques approuvés par la FDA et de leurs retraits
PMID : 26984921 ·
C, h, a, r, l, e, s, , S, , D, a, y, ;, , D, a, v, i, d, , J, , P, a, r, k, ;, , F, r, e, d, e, r, i, c, k, , S, , R, o, z, e, n, s, h, t, e, y, n, ;, , N, a, n, a, , O, w, u, s, u, -, S, a, r, p, o, n, g, ;, , A, l, d, e, b, a, r, a, n, i, , G, o, n, z, a, l, e, z
Publicité
Résumé
The U.S. Food and Drug Administration (FDA) evaluates medical devices by two main pathways. The more stringent Premarket Approval (PMA) review requires clinical trials, and the Premarket Notification 510(k) process generally exempts devices from clinical trials if they prove to be substantially equivalent to existing devices. We hypothesized that orthopaedic devices are more likely to be cleared through the 510(k) process and thus are more susceptible to being recalled. Using the FDA's public da
Publicité
Source officielle
Voir sur PubMed →Données issues de PubMed / NCBI. Pour le texte intégral et les informations les plus récentes, consultez toujours la notice officielle.